Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.
Patients are learning to live with a chronic disease that will affect one in 5 people over age 40.
Rediscover the power of nature's exquisite complexity and the ways it has shaped culture and medicine.
Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.